Target intelligence / Profile preview

WD repeat domain 43 (WDR43)

Target
WDR43
Molecular classification
Other (WD repeat family protein), RNA-binding protein, ribosome biogenesis factor
01

Overview

WD repeat domain 43 (WDR43) is a protein-coding gene and essential ribogenesis factor that enables RNA binding and is highly involved in both ribosomal small subunit biogenesis and transcriptional regulation[1][5][4]. It acts by participating in the nucleolar processing of pre-18S ribosomal RNA and is required for the positive regulation of rRNA processing and transcription by RNA polymerase I. WDR43 is a part of the small subunit (SSU) processome, a critical ribonucleoprotein complex for the early steps of ribosome assembly. Emerging evidence suggests WDR43 also binds promoter-associated and nascent RNAs, facilitating release of elongation factors and paused RNA polymerase II, thereby regulating gene expression and maintaining stem cell pluripotency[1][5]. In disease states, WDR43 has been connected to cancer prognosis and immune cell infiltration, and is linked to ribosomopathy-related conditions like Diamond–Blackfan anemia[5]. No approved drugs are currently known to directly target WDR43, nor is there established therapeutic targeting of this molecule as of the most recent data[5].

Other names
KIAA0007UTP5NET12U3 small nucleolar RNA–associated protein 5 homologWD repeat–containing protein 43UTP5, small subunit (SSU) processome component, homolog (yeast)
02

Biological functions

Ribosome biogenesisRNA bindingrRNA processingRegulation of transcription by RNA polymerase I and IIMaintenance of stem cell pluripotencyRibosomal small subunit biogenesis
03

Disease associations

Cancer (implicated in prognosis and tumor immune cell infiltration)Diamond–Blackfan anemia (associated condition)Other (may influence immune modulation)
04

Biomarkers

May serve as a pan-cancer predictive indicator (prognostic biomarker in cancers)

Beyond the preview

Go deeper on WD repeat domain 43 (WDR43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WD repeat domain 43 (WDR43).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call